Veterinary Medicines

FEVAXYN QUATRIFEL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΓΑΤΕΣ

Not authorised
  • Chlamydia felis, strain Cello, Inactivated
  • Felid herpesvirus 1, strain 605, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
Download as PDF

Product identification

Medicine name:
FEVAXYN QUATRIFEL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΓΑΤΕΣ
Active substance:
  • Chlamydia felis, strain Cello, Inactivated
  • Felid herpesvirus 1, strain 605, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
Target species:
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Chlamydia felis, strain Cello, Inactivated
    1.69
    relative potency
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, strain 605, Inactivated
    1.39
    relative potency
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain 255, Inactivated
    1.26
    relative potency
    /
    1.00
    millilitre(s)
  • Feline panleucopenia virus, strain CU4, Inactivated
    8.50
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 20535/17/23-07-2018/K-0214602
Date of authorisation status change: